5-(4-(1,2,2-Triphenylvinyl)phenyl)thiophene-2-carbaldehyde, 98%, 5g

5-(3-Chloro-5-fluorophenyl)-5-oxovaleric acid, 95.0%, 1g

trans-4-Fluorotetrahydrofuran-3-amine hydrochloride, 98%, 5g

(R)-2-((5-Fluoro-2,4-dinitrophenyl)amino)propanamide, 95.0%, 1g

5-bromo-4-(thiophen-2-yl)thiazol-2-amine, 95.0%, 500mg

1-(CHLOROMETHYL)-4-PHENYL-3,4-DIHYDROISOQUINOLINE HCL, 95.0%, 1g

Tapón con labio abatible, Adecuado para, NS 12/21, 12,7, 12,3 mm, 50 Unidad(es)

2-Amino-6-chlorobenzo[b]thiophene-3-carbonitrile, 95+%, 250mg

4-Fluoro-2-methylbenzoic acid, 97.0%, 10g

Recipientes de reacción de seguridad, 1,5 ml, 1000 Unidad(es)

4,4-Difluoro-3-methylpiperidine hydrochloride, 97.0%, 250mg

Ethyl 5-bromo-2-(1,3-dioxoisoindolin-2-yl)thiophene-3-carboxylate, 97%, 100mg

2-Iodohippuric Acid>99.0%(T)25g